I last valued RITES in August of last year and found it vastly undervalued. I held the stock and it has since been a frustrating 6 months. The stock looks to be stuck in a limbo moving nowhere irrespective of the good results. I valued the stock again after they released their Q3 numbers. Here’s… Continue reading RITES Limited – IV
Category: Seasons
“I think that to one in sympathy with nature, each season, in turn, seems the loveliest.” ― Mark Twain
Redington (India) – IV
I valued Redington (India) in August last year after the release of their annual report. I was already holding the stock then and the new numbers still found the stock to be undervalued. I continued to hold the stock and it has been an ambivalent last 6 months. They released their Q3 numbers this past… Continue reading Redington (India) – IV
GAIL (India) – V
I valued Gail (India) 4 times over the last year with the latest being in November’21, I’ve always been bullish about the stock irrespective of it’s ambivalence over the last year. I still believe in the story and their recent growth and income metrics have outperformed my estimates. This is my latest valuation based on… Continue reading GAIL (India) – V
Granules India – II
I valued Granules back in July post their annual results and found it to be undervalued. I did not invest in it as the margin was not good enough. I kept tabs on it over the last 5 months and this is my valuation of Granules post their Q2 results. Numbers and Narratives Granules India… Continue reading Granules India – II
GAIL (India) – IV
I valued GAIL (India) back in August and arrived at an intrinsic valuation of ₹201.79. Since then, the stock has been disappointing with a lot of volatility and very little growth. They came out with their Q2 numbers recently and I revalued the company again. Numbers and Narratives Gail (India) is a major player in the… Continue reading GAIL (India) – IV
RITES Limited – III
I first valued RITES in May and found it vastly undervalued. I bought the stock then and held it after I revalued it in June. The last two months have been frustrating with the stock going nowhere. The company released their Q1 numbers last week and I took another look at the valuation. I decided… Continue reading RITES Limited – III
Redington (India) – III
I valued Redington (India) for the second time in May after the release of their FY21 numbers. I was already holding the stock then and the new numbers still found the stock to be undervalued. I continued to hold the stock and it had a stellar bull run the last 3 months. They released their… Continue reading Redington (India) – III
GAIL (India) – III
I valued GAIL (India) back in June for the second time in the last 6 months and had a bullish outlook on the stock. I had invested in it in April when I found it grossly undervalued and the stock moved towards my intrinsic value in those 2 months. The stock had since then regressed… Continue reading GAIL (India) – III
Aurobindo Pharma – I
I chose to value Aurobindo Pharma based on a screen of high growth, low PE ratio companies for which the EPS growth rate has been greater than stock price growth rate. Numbers and Narratives Aurobindo Pharma is a mature pharmaceutical company that is witnessing a second lease of growth. I expect it to continue growing… Continue reading Aurobindo Pharma – I
Equitas Small Finance Bank – I
I chose to value Equitas Small Finance Bank for the same reason I valued Federal Bank. They are the new age banks that are trying to gain market share through inorganic means by the way of tie-ups with neo banks. Numbers and Narratives Equitas Small Finance Bank is an up and coming bank still very… Continue reading Equitas Small Finance Bank – I